Zhang YJ - Search Results

Year	Number of Results
1981	1
1982	4
1984	5
1985	4
1986	7
1987	4
1988	1
1989	5
1990	6
1991	8
1992	4
1993	12
1994	15
1995	13
1996	8
1997	12
1998	8
1999	13
2000	15
2001	15
2002	27
2003	31
2004	42
2005	62
2006	88
2007	70
2008	97
2009	108
2010	121
2011	155
2012	188
2013	200
2014	192
2015	234
2016	213
2017	241
2018	230
2019	256
2020	256
2021	280
2022	288
2023	232
2024	103

1

Electro-scalp acupuncture regulates the expression of CYP27a1/b1, CYP24a and related inflammatory cytokines in ischemic cortex of rats with middle cerebral artery occlusion.

Zhang SY, Yuan B, Luo WJ, Zhu LG, Zhang YJ, Tian T, Peng XY, Wang JH. Zhang SY, et al. Among authors: zhang yj. Zhen Ci Yan Jiu. 2024 May 25;49(5):463-471. doi: 10.13702/j.1000-0607.20221351. Zhen Ci Yan Jiu. 2024. PMID: 38764117 Chinese, English.

2

The Role of the Tissue Perfusion Index in Predicting Disease Severity and Prognosis in Patients with Severe and Critical COVID-19.

Lin WT, Zhang YJ, Yan MK, Cai XT, Cai XE, Xu J. Lin WT, et al. Among authors: zhang yj. J Intensive Care Med. 2024 May 15:8850666241253162. doi: 10.1177/08850666241253162. Online ahead of print. J Intensive Care Med. 2024. PMID: 38748540

3

Dynamic changes in body composition during XELOX/SOX chemotherapy in patients with gastric cancer.

Li ZH, Xu T, Zhang YJ, Jiang JH, Mi YZ, Li JX, Shen J, Fu YR, Qin BY, Lin F, Fu DJ, Yue MJ, Ma SM, Li QF. Li ZH, et al. Among authors: zhang yj. Front Oncol. 2024 Apr 30;14:1309681. doi: 10.3389/fonc.2024.1309681. eCollection 2024. Front Oncol. 2024. PMID: 38746684 Free PMC article.

4

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.

Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: zhang yj. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.

5

Safety and efficacy of Yaobitong capsules for lumbar disc herniation: A multicenter, randomized, double-blinded, parallel, positive-controlled clinical trial.

Zhao Y, Huang SR, Zhang YJ, Chen YQ, Liu WG, Gu FS, Wen H, Xu XL, Chen JY, Jin DX, Yin H, Dong Z, Yuan WA, Zhan HS. Zhao Y, et al. Among authors: zhang yj. Adv Clin Exp Med. 2024 May 13. doi: 10.17219/acem/185523. Online ahead of print. Adv Clin Exp Med. 2024. PMID: 38739103

6

Constructing an Asymmetric Covalent Triazine Framework to Boost the Efficiency and Selectivity of Visible-Light-Driven CO₂ Photoreduction.

Qi GD, Ba D, Zhang YJ, Jiang XQ, Chen Z, Yang MM, Cao JM, Dong WW, Zhao J, Li DS, Zhang Q. Qi GD, et al. Among authors: zhang yj. Adv Sci (Weinh). 2024 May 13:e2402645. doi: 10.1002/advs.202402645. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38738739

7

Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.

Li JX, Shu N, Zhang YJ, Tong QS, Wang L, Zhang JY, Du JZ. Li JX, et al. Among authors: zhang yj. ACS Appl Mater Interfaces. 2024 May 12. doi: 10.1021/acsami.4c01563. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38735053

8

Proteomics Study of Benzene Metabolite Hydroquinone Induced Hematotoxicity in K562 Cells.

Jin YS, Yi ZC, Zhang YJ, Rong L, Yu CH. Jin YS, et al. Among authors: zhang yj. Biomed Environ Sci. 2024 Apr 20;37(4):341-353. doi: 10.3967/bes2024.039. Biomed Environ Sci. 2024. PMID: 38727157 Free article.

9

Pancreatic mucinous adenocarcinoma has different clinical characteristics and better prognosis compared to non-specific PDAC: A retrospective observational study.

Liu J, Zhang YJ, Zhou J, Zhang ZJ, Wen Y. Liu J, et al. Among authors: zhang yj. Heliyon. 2024 Apr 26;10(9):e30268. doi: 10.1016/j.heliyon.2024.e30268. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720717 Free PMC article.

10

Phenolic constituents with potent α-glucosidase inhibitory and cytotoxic activities from Rumex nepalensis var. remotiflorus.

Li JJ, Wang XX, Li YM, Li N, Zhu HT, Eshbakova KA, Zhang YJ. Li JJ, et al. Among authors: zhang yj. Phytochemistry. 2024 May 6;223:114122. doi: 10.1016/j.phytochem.2024.114122. Online ahead of print. Phytochemistry. 2024. PMID: 38710376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3,512 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3,512 results

Results by year